Cargando…
Mangiferin supplementation improves serum lipid profiles in overweight patients with hyperlipidemia: a double-blind randomized controlled trial
Our previous studies have shown that mangiferin decreased serum triglycerides and free fatty acids (FFAs) by increasing FFAs oxidation in both animal and cell experiments. This study sought to evaluate the effects of mangiferin on serum lipid profiles in overweight patients with hyperlipidemia. Over...
Autores principales: | Na, Lixin, Zhang, Qiao, Jiang, Shuo, Du, Shanshan, Zhang, Wei, Li, Ying, Sun, Changhao, Niu, Yucun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437311/ https://www.ncbi.nlm.nih.gov/pubmed/25989216 http://dx.doi.org/10.1038/srep10344 |
Ejemplares similares
-
Mangiferin Decreases Plasma Free Fatty Acids through Promoting Its Catabolism in Liver by Activation of AMPK
por: Niu, Yucun, et al.
Publicado: (2012) -
Mangiferin Improved Palmitate-Induced-Insulin Resistance by Promoting Free Fatty Acid Metabolism in HepG2 and C2C12 Cells via PPARα: Mangiferin Improved Insulin Resistance
por: Zhang, Qiao, et al.
Publicado: (2019) -
Study of the interaction between self-assembling peptide and mangiferin and in vitro release of mangiferin from in situ hydrogel
por: Meng, Cui, et al.
Publicado: (2019) -
Nanostructured Lipid Carriers Aimed to the Ocular Delivery of Mangiferin: In Vitro Evidence
por: Santonocito, Debora, et al.
Publicado: (2023) -
Screening, Characterization and Evaluation of Mangiferin Polymorphs
por: Yang, Shiying, et al.
Publicado: (2020)